Pascual-Figal D, Nunez J, Perez-Martinez MT, Gonzalez-Juanatey JR, Taibo-Urquia M, Llacer Iborra P, Delgado J, Villar S, Mirabet S, Aimo A, Riquelme-Perez A, Anguita Sanchez M, Martinez-Selles M, Noguera-Velasco JA, Ibanez B, Bayes-Genis A; COLICA investigators. Colchicine in acutely decompensated heart failure: the COLICA trial. Eur Heart J. 2024 Aug 30;45(45):4826-36. doi: 10.1093/eurheartj/ehae538. Online ahead of print. PubMed PMID: 39211951; PubMed Central PMCID: PMC11637759.
AÑO: 2024; IF: 37.6
|
Pastor-Pérez F.J., Garrido-Bravo I.P., Peñafiel-Verdú P., Fernández-Villa N., Manzano-Fernández S., Oliva-Sandoval M.J., Pérez-Martínez M.T., Caro-Martínez C., Hernández-Vicente Á., Pascual-Figal D.A. Withdrawal of drug therapy in responders to cardiac resynchronization therapy: rationale and design of the REMOVE trial. Revista Espanola de Cardiologia. October 2024. 77:851-858. 10.1016/j.recesp.2024.02.020
AÑO: 2024; IF: 7.2
|
Pascual-Figal D.A., Hernández-Vicente A., Pastor-Pérez F., Martínez-Sellés M., Solé-González E., Alvarez-García J., García-Pavía P., Varela-Román A., Sánchez P.L., Delgado J.F., Noguera-Velasco J.A., Bayes-Genis A. N-terminal pro-B-type natriuretic peptide post-discharge monitoring in the management of patients with heart failure and preserved ejection fraction – a randomized trial: The NICE study. European Journal of Heart Failure. April 2024. 26:776-784. 10.1002/ejhf.3222
AÑO: 2024; IF: 16.9
|
Arnaldos-Carrillo M, Noguera-Velasco JA, Martinez-Ardil IM, Riquelme-Perez A, Cebreiros-Lopez I, Hernandez-Vicente A, Ros-Lucas JA, Khan A, Bayes-Genis A, Pascual-Figal D. Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19. Med Clin (Barc). 2023 Sep 8;161(5):185-191. doi: 10.1016/j.medcli.2023.04.005. Epub 2023 Apr 11. PubMed PMID: 37137804; PubMed Central PMCID: PMC10086099.
AÑO: 2023; IF: 2.6
|
Ros-Lucas JA, Pascual-Figal DA, Noguera-Velasco JA, Hernandez-Vicente A, Cebreiros-Lopez I, Arnaldos-Carrillo M, Martinez-Ardil IM, Garcia-Vazquez E, Aparicio-Vicente M, Solana-Martinez E, Ruiz-Martinez SY, Fernandez-Mula L, Andujar-Espinosa R, Fernandez-Suarez B, Sanchez-Caro MD, Penalver-Mellado C, Ruiz-Lopez FJ. CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia. Sci Rep. 2022 Apr 25;12(1):6738. doi: 10.1038/s41598-022-10726-7. PubMed PMID: 35469047; PubMed Central PMCID: PMC9037059.
AÑO: 2022; IF: 4.6
|